Costs and consequences of direct-to-consumer advertising for clopidogrel in Medicaid

Publication Topics

Data and Infrastructure
Economics and Organization
Health Human Resources
Health Technology Assessment
Knowledge Translation
Pharmaceutical Policy
Population Health
Primary Health Care
Quality, Access and Evaluation
Workplace Health and Safety

Costs and consequences of direct-to-consumer advertising for clopidogrel in Medicaid

Law, M.R.; Soumerai, S.B.; Adams, A.S.; Majumdar, S.R.

Archives of internal medicine, Am Med Assoc, Volume 169, Issue 21, p.1969 (2009)

Journal Article

UBC Centre for Health Services and Policy Research
201 - 2206 East Mall, Vancouver BC, V6T 1Z3
Tel: 604.822.4969
Fax: 604.822.5690
E-mail: enquire@chspr.ubc.ca

The University of British Columbia

Advancing world-class health services & policy research and training on issues that matter to Canadians

Costs and consequences of direct-to-consumer advertising for clopidogrel in Medicaid

Research

Publication Topics

Costs and consequences of direct-to-consumer advertising for clopidogrel in Medicaid

Law, M.R.; Soumerai, S.B.; Adams, A.S.; Majumdar, S.R.